BioArctic AB (publ) (BRCTF)
OTCMKTS · Delayed Price · Currency is USD
19.34
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of $1.91 billion as of August 1, 2025. Its market cap has decreased by -2.66% in one year.
Market Cap
1.91B
Enterprise Value
1.83B
Revenue
151.16M
Ranking
n/a
PE Ratio
21.27
Stock Price
$19.34
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 315.33M to 1.91B, an increase of 505.98%. That is a compound annual growth rate of 25.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.91B | 19.69% |
| Dec 30, 2024 | 1.60B | -31.92% |
| Dec 29, 2023 | 2.35B | 1.97% |
| Dec 30, 2022 | 2.30B | 98.17% |
| Dec 30, 2021 | 1.16B | 13.19% |
| Dec 30, 2020 | 1.03B | 14.35% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |